ArticleNucleic acids research2026
TEDD: a comprehensive database for translation efficiency dynamics.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Translation, a core process in central dogma, is essential for gene expression and determination of biological phenotypes. High-throughput RNA-seq, Ribo-seq, and RNC-seq have enabled large-scale measurement of translation efficiency dynamics, yet systematic quantification and integration of translation efficiency (TE), initiation efficiency (translation ratio, TR), and elongation speed (elongation velocity index, EVI) at both gene and transcript levels across diverse biological contexts remain limited, even though their context-specific regulation-together with associated UTR features-plays key roles in development, homeostasis, and disease. To address this gap, we present TEDD (https://ngdc.cncb.ac.cn/tedd), a comprehensive database for exploring human TE, TR, and EVI with a focus on regulatory 5'/3' UTR features. TEDD integrates 1518 RNA-seq, Ribo-seq, and RNC-seq samples from 143 human projects (279 datasets) covering 24 tissues/cell types, 74 cell lines, and 52 conditions. Metrics are calculated at both gene and transcript levels, paired with detailed UTR annotations for fine-grained investigation of translational regulation. With user-friendly browsing, search, and download functions, TEDD offers an integrated online platform for multi-dimensional comparisons across genes, transcripts, Kyoto Encyclopedia of Genes and Genomes/Gene Ontology-defined gene sets, and UTR elements, providing a valuable resource for studying translational control and supporting basic and translational applications in messenger RNA vaccine design, synthetic biology, gene therapy, and enzyme engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.